OKYO Pharma Limited
OKYO
$1.61
$0.042.55%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 56.84% | 66.13% | 72.03% | 53.95% | 35.62% |
| Total Depreciation and Amortization | -26.67% | -29.41% | -31.58% | -30.00% | -28.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.43% | -42.68% | -72.84% | -11.20% | 196.12% |
| Change in Net Operating Assets | -161.65% | -109.80% | -39.06% | -23.54% | -13.71% |
| Cash from Operations | -5.41% | 60.50% | 80.92% | 76.81% | 73.26% |
| Capital Expenditure | -- | -- | -- | 60.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 60.00% | -- |
| Total Debt Issued | 52,577.78% | 105,355.56% | -- | -52.41% | -99.91% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 98.40% | -19.94% | -72.53% | -70.48% | -69.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 132.62% | 1.20% | -57.22% | -69.48% | -76.07% |
| Foreign Exchange rate Adjustments | 80.34% | 48.87% | -272.33% | -471.66% | -616.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 613.04% | 203.08% | 122.81% | 104.02% | -200.06% |